Sanofi-Aventis Asia Pacific R&D Head Frank Jiang Sees Progress And Promise In Research Alliances Across China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - As the Paris-headquartered Sanofi-Aventis expands its matrix of research alliances across China, this virtual R&D web is beginning to churn out tangible signs of progress and promise, according to a high-ranking Sanofi scientist based in China
You may also be interested in...
During Shanghai Visit PhRMA Chairman Calls For Regulatory Systems To Support Innovation
During a three-day visit in Shanghai, PhRMA Chairman Robert Hugin met local stakeholders and outlined the organization’s advocacy priorities in China amidst the evolving Drug Administration Law.
During Shanghai Visit PhRMA Chairman Calls For Regulatory Systems To Support Innovation
During a three-day visit in Shanghai, PhRMA Chairman Robert Hugin met local stakeholders and outlined the organization’s advocacy priorities in China amidst the evolving Drug Administration Law.
Sanofi Continues Search For Novel Compounds In Asia, Inking Deal With India's Glenmark For Phase I Biologic
Deal is first for a biological candidate from India.